§ Funding Round
TME Pharma raised $2.8M Series D Plus venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
IBG Sachsen-Anhalt | — | — |
| Organization | — | |
Oppenheim Asset Management Services | — | — |
| Organization | — | |
The Dow Chemical Company | — | — |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$97.3M
Top Valuation
-
TME Pharma raised $2.8M in a Series D Plus round.
The round was announced on 10/12/10.
